Black Rock Inc. Vera Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,337,672 shares of VERA stock, worth $141 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,337,672
Previous 3,318,964
0.56%
Holding current value
$141 Million
Previous $143 Million
15.62%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$182 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$167 Million0.02% of portfolio
-
Abingworth LLP London, X02.96MShares$125 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$118 Million11.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$109 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.14B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...